Skip to Main Content

CADENCE makes Parkinson's disease trials smarter and more cost-effective. This AI-driven pipeline pinpoints the common, ancestry-specific risk alleles that define genetic subtypes — enabling precision enrollment so expensive trials recruit the right patients from the start. Validated in Parkison's disease database (PPMI), these alleles are enriched in real patients and biomarker status tracks genotype. Built with Claude, from public data to trial-ready insight.

Team

Placement

Participant

More from Built with Claude: Life Sciences

What I built. Lazarus is an agent that takes a dead research repository that is open, cited, and no longer runnable, and turns it back into a callable…

DoctorDean project preview

Diffuse midline glioma is a paediatric brainstem cancer that is almost uniformly fatal: about ninety percent of children die within two years, and the first…

Faith Ogundimu project preview

Hippocampus AI is the memory and reasoning engine for scientific discovery. Every experiment generates valuable knowledge, but that knowledge becomes…

Disruptors project preview

I used Claude to train a protein language model that can generate an extremophilic version of any enzyme, maintaining its function, while allowing it to…

Jaymin project preview

Many primates are sexually dichromatic — males and females are different colors. I wanted to know how that trait is built genetically, and how it evolved…

www.loom.com/…

About Trialign is a patient-facing clinical trial matcher for oncology. A patient pastes a clinical note, uploads a record, or connects their EHR via SMART on…

Trialign project preview